EPISODE · Mar 31, 2014 · 6 MIN
Podcast: Drug That May Slow Parkinson’s Progression Granted $23 Million from NIH for Phase III Testing
from The Michael J. Fox Foundation Parkinson's Podcast
Tanya Simuni, MD, principal investigator of the STEADY-PD, and MJFF CEO Todd Sherer talk about the study of isradipine, recently granted $23 million from the NIH for Phase III testing.Mentioned in this episode:Researchers are studying the link between sense of smell and brain health. People with and without Parkinson's can help by taking a scratch-and-sniff test. It’s free, mailed to your home and takes just 15 minutes to complete. mysmelltest.org/getstarted
Embed this episode
What this episode covers
Tanya Simuni, MD, principal investigator of the STEADY-PD, and MJFF CEO Todd Sherer talk about the study of isradipine, recently granted $23 million from the NIH for Phase III testing.
NOW PLAYING
Podcast: Drug That May Slow Parkinson’s Progression Granted $23 Million from NIH for Phase III Testing
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.